Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors

QR Code

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors

Steven H Ferris,1 Martin Farlow21Alzheimer's Disease Center, Comprehensive Center on Brain Aging, New York University Langone Medical Center, New York, NY, 2Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USAAbstract: Alzheimer's disease is character...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ferris SH, Farlow M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Alzheimer's disease donepezil cognition language communication clinical trials Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/fd5f8ba0d0fd4f6fbfa427bb8e86b4a7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
par: Zhang N, et autres
Publié: (2018)

Alzheimer’s disease and language impairments: social intervention and medical treatment
par: Klimova B, et autres
Publié: (2015)

Rehabilitating a brain with Alzheimer's: a proposal
par: Gonzalo Emiliano Aranda-Abreu, et autres
Publié: (2011)

Physical activity can improve cognition in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials
par: Du Z, et autres
Publié: (2018)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
par: Yoshiyuki Kagawa, et autres
Publié: (2021)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
par: Pai MC, et autres
Publié: (2015)

Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology
par: Sacco G, et autres
Publié: (2012)

Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience
par: Ding B, et autres
Publié: (2014)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
par: Jelcic N, et autres
Publié: (2014)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
par: Noll Campbell, et autres
Publié: (2008)

Electroencephalography-driven approach to prodromal Alzheimer's disease diagnosis: from biomarker integration to network-level comprehension
par: Moretti DV
Publié: (2016)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
par: Chen J, et autres
Publié: (2019)

Randomised Controlled Trial Of The Effect Of Tai Chi On Postural Balance Of People With Dementia
par: Nyman SR, et autres
Publié: (2019)

Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
par: Liang JH, et autres
Publié: (2018)

Mild cognitive impairment and its management in older people
par: Eshkoor SA, et autres
Publié: (2015)

FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease
par: Paroni G, et autres
Publié: (2014)

Rivastigmine in the treatment of Alzheimer's disease: an update
par: Maria Luisa Onor, et autres
Publié: (2007)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
par: Aydin EY, et autres
Publié: (2020)

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study
par: Ohnuma T, et autres
Publié: (2016)

Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews
par: Marta Pérez-Gómez Moreta, et autres
Publié: (2021)

Effectiveness of weekly cognitive stimulation therapy for people with dementia and the additional impact of enhancing cognitive stimulation therapy with a carer training program
par: Cove J, et autres
Publié: (2014)

Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors
par: Wang Q, et autres
Publié: (2014)

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
par: Celina S. Liu, et autres
Publié: (2021)

Late onset Alzheimer’s disease in older people
par: Ahmet Turan Isik
Publié: (2010)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
par: TSUJITA,MIKI, et autres
Publié: (2007)

Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial
par: Yuda N, et autres
Publié: (2020)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
par: Youn YC, et autres
Publié: (2017)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
par: Bektaş O, et autres
Publié: (2015)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
par: Ben Seltzer
Publié: (2009)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
par: Subramanian Madhusoodanan, et autres
Publié: (2008)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
par: An SS, et autres
Publié: (2016)

Long noncoding RNAs and Alzheimer's disease
par: Luo Q, et autres
Publié: (2016)

Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease
par: Gregory A Jicha, et autres
Publié: (2010)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
par: Muratli S, et autres
Publié: (2015)

Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer’s disease: a randomized controlled clinical trial
par: Zhao J, et autres
Publié: (2018)

Occupational activity and cognitive reserve: implications in terms of prevention of cognitive aging and Alzheimer’s disease
par: Adam S, et autres
Publié: (2013)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
par: Li XH, et autres
Publié: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
par: Cai Y, et autres
Publié: (2015)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
par: Yuan J, et autres
Publié: (2013)

Genes associated with Alzheimer's disease: an overview and current status
par: Giri M, et autres
Publié: (2016)